Log in or Sign up for Free to view tailored content for your specialty!
Cutaneous Oncology News
Differences in BCC subtype reporting suggest gap in delivery of care
A lack of histologic subtyping in basal cell carcinoma may put patients at risk for inadequate or inappropriate therapy, according to researchers who explored the importance of subtyping in a retrospective study throughout various practice settings.
Age a key factor when considering melanoma treatment
As people age, the pattern, timing and extent of distant metastasis change and should be considered when treating melanoma.
Log in or Sign up for Free to view tailored content for your specialty!
Dermatologist shares tips to tackle climate change
Climate change is a solvable problem, and physicians have a critical role to play in depoliticizing the issue and encouraging solutions, Sarah J. Coates, MD, from the department of dermatology, University of California, San Francisco, and colleagues wrote in a recent viewpoint in JAMA Dermatology.
Melanoma treatment at high-volume centers improves long-term survival
Treatment for primary nonmetastatic melanoma at high-volume facilities is associated with improved long-term patient survival, with academic centers reporting the best outcomes, according to a study.
Suture spacing yields similar cosmetic outcomes during linear wound closures
Researchers reported no statistically significant difference in wound cosmesis or total complications between running cutaneous sutures spaced 2 mm or 5 mm apart among patients who underwent Mohs procedures or surgical excision on the head or neck.
Corticosteroid use for immune-mediated adverse events often does not match guidelines
FORT WORTH, Texas — An evaluation of physician prescribing practices showed utilization of corticosteroids for management of immune-mediated adverse events among patients with cancer who received immune checkpoint inhibitors often was not based on national guidelines, according to study results presented at HOPA Ahead 2019.
Genetic testing can detect melanoma earlier, but tailored approach is required
Genetic testing can help increase early detection of melanoma among patients and their family members, according to a presenter at HemOnc Today New York.
Standards evolve for adjuvant therapy of melanoma
NEW YORK — A strong rationale exists for offering adjuvant therapy to certain patients with melanoma, but several aspects of treatment remain controversial, according to a presenter at HemOnc Today New York.
NCI scientist to receive Szent-Györgyi Prize for Progress in Cancer Research
Steven A. Rosenberg, MD, PhD, will receive the 2019 Szent-Györgyi Prize for Progress in Cancer Research.
Proposed FDA sunscreen rule could save lives, reduce confusion
The FDA has proposed a rule that it says would update regulatory requirements for most sunscreen products sold in the United States.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read